There was a lot of controversy when the FDA approved an expensive, and possibly ineffective drug for Alzheimer's patients last year. Turns out this has become a trend---the FDA has been busy greenlighting several contested drugs under so-called "accelerated approval"---we'll take a closer look.
And which of the COVID-induced changes to the American workplace will be sticking around for good........and which ones will be tossed out with your old face masks?
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
View all episodes
By Audacy
3.8
262262 ratings
There was a lot of controversy when the FDA approved an expensive, and possibly ineffective drug for Alzheimer's patients last year. Turns out this has become a trend---the FDA has been busy greenlighting several contested drugs under so-called "accelerated approval"---we'll take a closer look.
And which of the COVID-induced changes to the American workplace will be sticking around for good........and which ones will be tossed out with your old face masks?
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
25,861 Listeners
14,372 Listeners
1,734 Listeners
710 Listeners
1,363 Listeners
1,172 Listeners
6,336 Listeners
743 Listeners
4,681 Listeners
279 Listeners
112,574 Listeners
56,419 Listeners
332 Listeners
1,451 Listeners
9,508 Listeners
14,307 Listeners
722 Listeners
2,402 Listeners
16,249 Listeners
2,396 Listeners
1,269 Listeners
6,417 Listeners
6,379 Listeners
414 Listeners
738 Listeners